Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    23129602 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study
Condition: Hypercholesterolemia, Familial
Interventions: Biological: Evolocumab;   Biological: Placebo
2 Recruiting A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Genetic: AAV directed hLDLR gene therapy
3 Active, not recruiting Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
Conditions: Atherosclerotic Cardiovascular Disease;   Familial Hypercholesterolemia;   Diabetes
Intervention: Drug: ALN-PCSSC

Study has passed its completion date and status has not been verified in more than two years.